Rollup theory of harm ‘extends well outside’ PE sector, US FTC official says
Companies outside the private equity industry that engage in anticompetitive rollup schemes to hike prices are just as likely to elicit scrutiny from the Federal Trade Commission as PE firms, because...To view the full article, register now.
Already a subscriber? Click here to view full article